BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8168773)

  • 41. Treatment compliance among prenatal care patients with substance abuse problems.
    Clark KA; Dee DL; Bale PL; Martin SL
    Am J Drug Alcohol Abuse; 2001 Feb; 27(1):121-36. PubMed ID: 11373030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics.
    Pegues DA; Engelgau MM; Woernle CH
    Public Health Rep; 1994; 109(4):530-8. PubMed ID: 8041853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Substance abuse among women.
    Quinby PM; Graham AV
    Prim Care; 1993 Mar; 20(1):131-40. PubMed ID: 8464935
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disposition and health outcomes among infants born to mothers with no prenatal care.
    Friedman SH; Heneghan A; Rosenthal M
    Child Abuse Negl; 2009 Feb; 33(2):116-22. PubMed ID: 19272644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of pregnant women who engage in binge alcohol consumption.
    Gladstone J; Levy M; Nulman I; Koren G
    CMAJ; 1997 Mar; 156(6):789-94. PubMed ID: 9084383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Perspectives of pregnant substance-using women: findings from the California Perinatal Needs Assessment.
    Klein D; Zahnd E
    J Psychoactive Drugs; 1997; 29(1):55-66. PubMed ID: 9110266
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adolescent Pregnancy Guidelines.
    Fleming N; O'Driscoll T; Becker G; Spitzer RF;
    J Obstet Gynaecol Can; 2015 Aug; 37(8):740-756. PubMed ID: 26474231
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reducing substance abuse during pregnancy. Discriminating among levels of response in a prenatal setting.
    Corse SJ; Smith M
    J Subst Abuse Treat; 1998; 15(5):457-67. PubMed ID: 9751005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Is drug prohibition an effective tool? An analysis from the forensic viewpoint].
    Stratenwerth G
    Psychiatr Prax; 1994 Jan; 21(1):3-6. PubMed ID: 8146243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Description of medicosocial profiles of pharmacodependent subjects consulting addictology centres using a computerized database].
    Landreat MG; Vigneau CV; Bronnec MG; Sebille-Rivain V; Venisse JL; Jolliet P
    Encephale; 2011 Dec; 37(6):418-24. PubMed ID: 22137213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neonatal findings among children of substance-abusing women attending a special child welfare clinic in Norway.
    Hjerkinn B; Rosvold EO; Lindbaek M
    Scand J Public Health; 2009 Sep; 37(7):751-7. PubMed ID: 19622548
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Substance use and treatment seeking in young offenders on community orders.
    Lennings CJ; Kenny DT; Nelson P
    J Subst Abuse Treat; 2006 Dec; 31(4):425-32. PubMed ID: 17084797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The special prenatal clinic: one approach to women and substance abuse.
    Carrington BW; Loftman PO; Jones K; Williams D; Mitchell JL
    J Womens Health; 1998 Mar; 7(2):189-93. PubMed ID: 9555683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterizing pregnant drug-dependent women in treatment and their children.
    Kissin WB; Svikis DS; Morgan GD; Haug NA
    J Subst Abuse Treat; 2001 Jul; 21(1):27-34. PubMed ID: 11516924
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developmental vicissitudes that promote drug abuse in adolescents.
    Trad PV
    Am J Drug Alcohol Abuse; 1994 Nov; 20(4):459-81. PubMed ID: 7832180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors for disruption in primary caregiving among infants of substance abusing women.
    Nair P; Black MM; Schuler M; Keane V; Snow L; Rigney BA; Magder L
    Child Abuse Negl; 1997 Nov; 21(11):1039-51. PubMed ID: 9422825
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Southcentral Foundation--Dena A Coy: a model program for the treatment of pregnant substance-abusing women.
    Namyniuk L; Brems C; Carson S
    J Subst Abuse Treat; 1997; 14(3):285-95. PubMed ID: 9306304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of case management on retention in prenatal substance abuse treatment.
    Laken MP; Ager JW
    Am J Drug Alcohol Abuse; 1996 Aug; 22(3):439-48. PubMed ID: 8841690
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessing risk in families affected by substance abuse.
    Olsen LJ; Allen D; Azzi-Lessing L
    Child Abuse Negl; 1996 Sep; 20(9):833-42. PubMed ID: 8886467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Women in recovery. Their perceptions of treatment effectiveness.
    Nelson-Zlupko L; Dore MM; Kauffman E; Kaltenbach K
    J Subst Abuse Treat; 1996; 13(1):51-9. PubMed ID: 8699543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.